Efficacy, Safety, and Tolerability of Rimegepant 75 Mg, an Oral CGRP Receptor Antagonist, for the Acute Treatment of Migraine: Results from a Double-blind, Randomized, Placebo-controlled Trial, Study 302
HEADACHE(2018)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要